Valsartan, Amlodipine and Hydrochlorothiazide

Therapeutic indications

Valsartan, Amlodipine and Hydrochlorothiazide is indicated for:

Essential hypertension

Population group: only adults (18 years old or older)

Treatment of essential hypertension as substitution therapy in adult patients whose blood pressure is adequately controlled on the combination of amlodipine, valsartan and hydrochlorothiazide (HCT), taken either as three single-component formulations or as a dual-component and a single-component formulation.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

5 mg/160 mg/12.5 mg, 10 mg/160 mg/12.5 mg, 5 mg/160 mg/25 mg, 10 mg/160 mg/25 mg or 10 mg/320 mg/25 mg of amlodipine/valsartan/hydrochlorothiazide once daily

Contraindications

Valsartan, Amlodipine and Hydrochlorothiazide is contraindicated in the following cases:

Pregnancy

Refractory hypokalaemia, hyponatraemia, hypercalcaemia, and symptomatic hyperuricaemia

at least one of

Hypokalemia
Hyponatremia
Hypercalcemia
Hyperuricemia

< Previous: Overview

Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.